Loading...
Genmab and PDL Biopharma close sale of antibody manufacturing facility
17-Mar-2008
Advertisement
Genmab A/S and PDL BioPharma, Inc. announced the closing of the previously announced transaction under which Genmab has acquired PDL's antibody manufacturing facility located in Brooklyn Park, Minnesota, USA for USD 240 million in cash. The transaction was first announced on February 21, 2008.